| Amal Saha, MD | |
|
1545 Atlantic Ave, Brooklyn, NY 11213-1122 | |
| (718) 613-4000 | |
| Not Available |
| Full Name | Amal Saha |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 49 Years |
| Location | 1545 Atlantic Ave, Brooklyn, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003861220 | NPI | - | NPPES |
| 01532778 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 189842 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Interfaith Psychiatry Services, P.c. | 0244409613 | 9 |
News Archive
Proton therapy results in fewer side effects than traditional X-ray radiation therapy for many cancer patients, according to a new study led by Washington University School of Medicine in St. Louis and the Perelman School of Medicine at University of Pennsylvania.
A team led by a Northwestern University biomedical engineer has found that combining novel optical technologies with a common colon cancer screening test may allow doctors to more accurately detect the presence of colon cancer, particularly in women.
Cell Therapeutics, today announced that the Office of New Drugs of the U.S. Food and Drug Administration after carefully reviewing the materials CTI submitted in support of its appeal, the reviews of the New Drug Application for pixantrone prepared by the FDA staff, the transcript of the March 22, 2010 Oncology Drugs Advisory Committee meeting and consulting with the Center for Drug Evaluation and Research's Deputy Director of Clinical Science and the Office of Biostatistics, concluded that accelerated approval of pixantrone NDA 022481 may not necessarily be out of reach based on a single controlled clinical trial, provided two key matters can be satisfactorily resolved.
Researchers at the Hebrew University of Jerusalem have discovered a method to potentially eliminate the tumor-risk factor in utilizing human embryonic stem cells. Their work paves the way for further progress in the promising field of stem cell therapy.
› Verified 6 days ago
| Entity Name | Interfaith Psychiatry Services, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487958559 PECOS PAC ID: 0244409613 Enrollment ID: O20110802000215 |
News Archive
Proton therapy results in fewer side effects than traditional X-ray radiation therapy for many cancer patients, according to a new study led by Washington University School of Medicine in St. Louis and the Perelman School of Medicine at University of Pennsylvania.
A team led by a Northwestern University biomedical engineer has found that combining novel optical technologies with a common colon cancer screening test may allow doctors to more accurately detect the presence of colon cancer, particularly in women.
Cell Therapeutics, today announced that the Office of New Drugs of the U.S. Food and Drug Administration after carefully reviewing the materials CTI submitted in support of its appeal, the reviews of the New Drug Application for pixantrone prepared by the FDA staff, the transcript of the March 22, 2010 Oncology Drugs Advisory Committee meeting and consulting with the Center for Drug Evaluation and Research's Deputy Director of Clinical Science and the Office of Biostatistics, concluded that accelerated approval of pixantrone NDA 022481 may not necessarily be out of reach based on a single controlled clinical trial, provided two key matters can be satisfactorily resolved.
Researchers at the Hebrew University of Jerusalem have discovered a method to potentially eliminate the tumor-risk factor in utilizing human embryonic stem cells. Their work paves the way for further progress in the promising field of stem cell therapy.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amal Saha, MD 34-30 84th St, Jackson Heights, NY 11372 Ph: (718) 613-4000 | Amal Saha, MD 1545 Atlantic Ave, Brooklyn, NY 11213-1122 Ph: (718) 613-4000 |
News Archive
Proton therapy results in fewer side effects than traditional X-ray radiation therapy for many cancer patients, according to a new study led by Washington University School of Medicine in St. Louis and the Perelman School of Medicine at University of Pennsylvania.
A team led by a Northwestern University biomedical engineer has found that combining novel optical technologies with a common colon cancer screening test may allow doctors to more accurately detect the presence of colon cancer, particularly in women.
Cell Therapeutics, today announced that the Office of New Drugs of the U.S. Food and Drug Administration after carefully reviewing the materials CTI submitted in support of its appeal, the reviews of the New Drug Application for pixantrone prepared by the FDA staff, the transcript of the March 22, 2010 Oncology Drugs Advisory Committee meeting and consulting with the Center for Drug Evaluation and Research's Deputy Director of Clinical Science and the Office of Biostatistics, concluded that accelerated approval of pixantrone NDA 022481 may not necessarily be out of reach based on a single controlled clinical trial, provided two key matters can be satisfactorily resolved.
Researchers at the Hebrew University of Jerusalem have discovered a method to potentially eliminate the tumor-risk factor in utilizing human embryonic stem cells. Their work paves the way for further progress in the promising field of stem cell therapy.
› Verified 6 days ago
Mario Gustave, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 585 Schenectady Ave, Brooklyn, NY 11203 Phone: 718-604-5281 | |
Matthew Thrun-nowicki, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 150 55th St, Brooklyn, NY 11220 Phone: 718-630-7000 | |
Zinaida Lyuboff, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 135 Ocean Pkwy, Suite 1u, Brooklyn, NY 11218 Phone: 718-614-6167 Fax: 718-769-0657 | |
Dr. Geraldine Orendain, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 760 Broadway, Woodhull Medical And Mental Health Center, Brooklyn, NY 11206 Phone: 718-963-5793 | |
Farokh Tarapore, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 1 Brookdale Plaza, Brookdale Univ Hosp & Med Ctr Dept Of Psychiatry, Brooklyn, NY 11212 Phone: 718-240-5678 Fax: 718-240-5986 | |
Jean Bien-aime, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 94-98 Manhattan Avenue, Cabs Health Center, Brooklyn, NY 11206 Phone: 718-388-0390 Fax: 718-486-5741 |